4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001209191-22-061094
Chief Executive Officer gave up 1,081 shares (to pay taxes)
- Chief Executive Officer acquired 3,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D Chief Executive Officer | 2022-12-11 | Option exercise | +3,125 | 40,998 | D | ||
| WEST MICHAEL D Chief Executive Officer | 2022-12-11 | Shares withheld for taxes | −1,081 | $0.59 | $638 | 39,917 | D |
| Derivatives | |||||||
| WEST MICHAEL D Chief Executive Officer | 2022-12-11 | Option exercise · Restricted Stock Units | −3,125 | 3,125 | D | ||
Loading xslF345X03/doc4.xml…